Patent · US Active

Method for preparing solution formulation for aerosol inhalation of naringenin

US12064412B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2019
Grant dateAug 20, 2024
Priority date
Expiry dateApr 18, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses a solution formulation for aerosol inhalation of naringenin and preparation method thereof. The formulation is prepared from 1 part by weight of naringenin, 15-30 parts by weight of hydroxypropyl β-cyclodextrin, a buffer-salt solution and an appropriate amount of an excipient. The preparation method includes: preparing a buffer-salt solution of a pH value of 7-8.5 by using the buffer salt, adding the naringenin into the buffer-salt solution, then adding the hydroxypropyl β-cyclodextrin, shaking in a constant-temperature air bath till complete dissolving and coating, adding an appropriate amount of the excipient, filtering, filling and sterilizing. The present invention, by firstly increasing the solubility of the free naringenin in the solvent by adjusting the pH value, and then coating the naringenin with the hydroxypropyl β-cyclodextrin, significantly increases the overall concentration of the naringenin in the solvent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.